• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • Product And Operating Company News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

< Prev | | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | .... 34 Next >
Biosense Webster Announces Launch of the CARTO® 3 MEM Base Version

August 13, 2012

BabyCenter® Drives Chrysler Brand's 2012 Town & Country Minivan Campaign

August 13, 2012

Crucell and Scripps Research discover and describe broad-spectrum antibodies against influenza B, a crucial link in development of universal flu therapies and vaccine

August 10, 2012

Updated Coding and Payment on the Horizon for Circulating Tumor Cell Testing

August 09, 2012

Ethicon Endo-Surgery Receives 510(K) Clearance For New HARMONIC ACE®+ Shears with Adaptive Tissue Technology

August 08, 2012

Johnson & Johnson Announces Discontinuation Of Phase 3 Development of Bapineuzumab Intravenous (IV) In Mild-To-Moderate Alzheimer's Disease

August 06, 2012

< Prev | | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • Product And Operating Company News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

This section contains multiple pages. Click on each page number to advance the page.
< Prev | | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | .... 34 Next >
Biosense Webster Announces Launch of the CARTO® 3 MEM Base Version

August 13, 2012

BabyCenter® Drives Chrysler Brand's 2012 Town & Country Minivan Campaign

August 13, 2012

Crucell and Scripps Research discover and describe broad-spectrum antibodies against influenza B, a crucial link in development of universal flu therapies and vaccine

August 10, 2012

Updated Coding and Payment on the Horizon for Circulating Tumor Cell Testing

August 09, 2012

Ethicon Endo-Surgery Receives 510(K) Clearance For New HARMONIC ACE®+ Shears with Adaptive Tissue Technology

August 08, 2012

Johnson & Johnson Announces Discontinuation Of Phase 3 Development of Bapineuzumab Intravenous (IV) In Mild-To-Moderate Alzheimer's Disease

August 06, 2012

< Prev | | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •